BiotechTube
Home/LIPAC Oncology/Michael Oefelein, MD, PhD, FACE
MO

Michael Oefelein, MD, PhD, FACE

Chief Medical Officer

LIPAC Oncology

Therapeutic Areas

Oncology

LIPAC Oncology Pipeline

DrugIndicationPhase
LiPaxNon-Muscle Invasive Bladder Cancer (NMIBC)Phase 2

Leadership Team at LIPAC Oncology

R“
Ramachandran “TR” Thirucote, PhD
Chairman & Chief Executive Officer
View full LIPAC Oncology profile